Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy
- PMID: 3558038
- DOI: 10.1016/0360-3016(87)90060-5
Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy
Abstract
Between June 1970 and April 1982, 592 patients with unilateral T1 and small T2 breast cancers were managed conservatively at the Institut Gustave-Roussy. The treatment policy for the axilla was to perform a lower axillary dissection and to proceed to axillary clearance ( +/- radiotherapy) in patients with axillary invasion by tumor (N+). Some N+ patients had only lower axillary dissection and radiotherapy. Five hundred fifty-eight patients underwent axillary surgery which was a lower axillary dissection in 374 patients (67%) and axillary clearance in 184 patients (33%). There was axillary invasion in 198 cases (36%). Only five patients relapsed in the axilla and the probability of axillary relapse at 5 years was 1.2%. There were no axillary relapses in N+ patients who had had an axillary clearance whether irradiated or not. The incidence of upper limb complications was significantly greater in patients undergoing axillary surgery and radiotherapy compared with axillary surgery alone (p less than 0.0001). It is concluded that a lower axillary dissection accurately identifies N-patients and an axillary clearance in N+ patients ensures good local control and avoids the morbidity associated with axillary irradiation.
Similar articles
-
Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit.Br J Surg. 2000 Feb;87(2):163-9. doi: 10.1046/j.1365-2168.2000.01345.x. Br J Surg. 2000. PMID: 10671921 Clinical Trial.
-
Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers.Radiother Oncol. 1988 Aug;12(4):273-80. doi: 10.1016/0167-8140(88)90016-3. Radiother Oncol. 1988. PMID: 3187067
-
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Orv Hetil. 2013. PMID: 24292111 Clinical Trial. Hungarian.
-
[Management of the axilla in breast cancer: evidences and unresolved issues].Orv Hetil. 2001 Sep 9;142(36):1941-50. Orv Hetil. 2001. PMID: 11680099 Review. Hungarian.
-
Is axillary dissection always indicated in invasive breast cancer?Oncology (Williston Park). 1997 Oct;11(10):1463-8; discussion 1468, 1473-9. Oncology (Williston Park). 1997. PMID: 9348554 Review.
Cited by
-
Prognostic factors and natural history in lymph node-negative breast cancer patients.Breast Cancer Res Treat. 1992;21(2):101-9. doi: 10.1007/BF01836956. Breast Cancer Res Treat. 1992. PMID: 1627813
-
Intraoperative assessment of axillary lymph node metastases in operable breast cancer.Breast Cancer Res Treat. 1996;40(2):179-85. doi: 10.1007/BF01806213. Breast Cancer Res Treat. 1996. PMID: 8879684 Clinical Trial.
-
Complications of Axillary Lymph Node Dissection in Treatment of Early Breast Cancer: A Comparison of MRM and BCS.Indian J Surg Oncol. 2011 Jun;2(2):126-32. doi: 10.1007/s13193-011-0078-2. Epub 2011 Jul 22. Indian J Surg Oncol. 2011. PMID: 22693405 Free PMC article.
-
Management of the Axilla in the Era of Breast Cancer Heterogeneity.Front Oncol. 2018 Apr 4;8:84. doi: 10.3389/fonc.2018.00084. eCollection 2018. Front Oncol. 2018. PMID: 29670853 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous